Research in Vermont

Alabama Clinical Trials Benefit Patients and the Economy

BIRMINGHAM, AL (December 4, 2013) – Working with Alabama research institutions, including several facilities in Birmingham, the nation’s biopharmaceutical research companies have conducted 3,431 clinical trials of new medicines in the state over the last 14 years, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). 

Research in Alabama

Nearly 400 Novel Medicines in Development for Infectious Diseases

America’s biopharmaceutical research companies are developing 394 new medicines for infectious diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). 

Infectious diseases were the leading cause of death in the United States until the 1920s

WASHINGTON, D.C. (December 4, 2013) – America’s biopharmaceutical research companies are developing 394 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Infectious Diseases Infographic

Medicines in Development: Infectious Diseases

4,710 Clinical Trials Conducted By Massachusetts Research Centers Total Includes 491 Trials Conducted In Worcester Since 1999

                              

Research in Massachusetts

Research in Nebraska

Pages

Subscribe to RSS - Innovation